Inventor
RABIZADEH SHAHROOZ
US85 patents
⚠️ This page may combine multiple inventors who share the name “RABIZADEH SHAHROOZ”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NANTOMICS LLC
16 patentsUS11421016B2Aug 23, 2022
Cancer neoepitopes
NANTOMICS LLC16 citations86
US11948687B2Apr 2, 2024
Deep learning models for region-of-interest determination
NANTOMICS LLC8 citations83
US11276479B2Mar 15, 2022
Tumor antigenicity processing and presentation
NANTOMICS LLC2 citations73
US11954596B2Apr 9, 2024
Weakly supervised learning with whole slide images
NANTOMICS LLC5 citations72
US11954856B2Apr 9, 2024
Real-time whole slide pathology image cell counting
NANTOMICS LLC1 citations72
US11443426B2Sep 13, 2022
Real-time whole slide pathology image cell counting
NANTOMICS LLC2 citations72
US11756651B2Sep 12, 2023
Method of treating a tumor in a patient based on an immune gene expression
NANTOMICS LLC4 citations71
US12195808B2Jan 14, 2025
Dynamic changes in circulating free RNA of neural tumors
NANTOMICS LLC0 citations63
US11821043B2Nov 21, 2023
Dynamic changes in circulating free RNA of neural tumors
NANTOMICS LLC0 citations63
US12406366B2Sep 2, 2025
Real-time whole slide pathology image cell counting
NANTOMICS LLC0 citations62
US11626187B2Apr 11, 2023
Systems, compositions, and methods for discovery of MSI and neoepitopes that predict sensitivity to checkpoint inhibitors
NANTOMICS LLC0 citations62
US11361841B2Jun 14, 2022
High-throughput identification of patient-specific neoepitopes as therapeutic targets for cancer immunotherapies
NANTOMICS LLC1 citations62
US10467523B2Nov 5, 2019
Methods and systems for predicting DNA accessibility in the pan-cancer genome
NANTOMICS LLC1 citations61
US12224066B2Feb 11, 2025
Deep learning models for region of interest determination
NANTOMICS LLC0 citations60
US12412639B2Sep 9, 2025
Method of characterizing a tumor based on an immune gene expression signature in regulatory T cell (Treg)-enriched tumor samples
NANTOMICS LLC0 citations59
US12205033B2Jan 21, 2025
Weakly supervised learning with whole slide images
NANTOMICS LLC0 citations59
NANT HOLDINGS IP LLC
13 patentsUS9765330B1Sep 19, 2017
Compositions and methods for reduction of allograft recognition and rejection
NANT HOLDINGS IP LLC21 citations94
US11207392B2Dec 28, 2021
Coordinated multi-prong cancer therapy
NANT HOLDINGS IP LLC5 citations84
US11071774B2Jul 27, 2021
Nant cancer vaccine
NANT HOLDINGS IP LLC2 citations73
US10793875B2Oct 6, 2020
Compositions and methods for viral delivery of neoepitopes and uses thereof
NANT HOLDINGS IP LLC3 citations73
US10533157B1Jan 14, 2020
Recombinant NK cells expressing co-stimulatory molecules
NANT HOLDINGS IP LLC2 citations73
US10344280B1Jul 9, 2019
Compositions and methods for reduction of allograft recognition and rejection
NANT HOLDINGS IP LLC3 citations73
US9750805B2Sep 5, 2017
Calcium flux agonists and methods therefor
NANT HOLDINGS IP LLC2 citations72
US9315464B1Apr 19, 2016
Small molecule inhibitors of influenza A RNA-dependent RNA polymerase
NANT HOLDINGS IP LLC3 citations72
US9422291B2Aug 23, 2016
Small molecule inhibitors of influenza A RNA-dependent RNA polymerase
NANT HOLDINGS IP LLC3 citations71
US11725186B2Aug 15, 2023
Recombinant NK cells expressing co-stimulatory molecules
NANT HOLDINGS IP LLC0 citations63
US11480572B2Oct 25, 2022
Live cell imaging systems and methods to validate triggering of immune response
NANT HOLDINGS IP LLC0 citations63
US11441160B2Sep 13, 2022
Compositions and methods for viral delivery of neoepitopes and uses thereof
NANT HOLDINGS IP LLC0 citations63
US10973852B2Apr 13, 2021
NK cells with altered CXCL12/CXCR4 signaling
NANT HOLDINGS IP LLC1 citations63
NANTCELL INC
7 patentsUS11229668B2Jan 25, 2022
Maximizing T-cell memory and compositions and methods therefor
NANTCELL INC3 citations73
US11154597B2Oct 26, 2021
Sequence arrangements and sequences for neoepitope presentation
NANTCELL INC2 citations73
US12516093B2Jan 6, 2026
Recombinant erIL-15 NK cells
NANTCELL INC1 citations64
US11590217B2Feb 28, 2023
Neoepitope vaccine and immune stimulant combinations and methods
NANTCELL INC1 citations63
US11564980B2Jan 31, 2023
Tumor treatment method with an individualized peptide vaccine
NANTCELL INC1 citations63
US11439697B2Sep 13, 2022
Nant cancer vaccine
NANTCELL INC0 citations62
US11221328B2Jan 11, 2022
Hypoxic NK cells and methods therefor
NANTCELL INC0 citations62
FIVE3 GENOMICS LLC
3 patentsUS11361844B2Jun 14, 2022
Systems, methods, and compositions for viral-associated tumors
FIVE3 GENOMICS LLC2 citations71
US10176295B2Jan 8, 2019
Systems, methods, and compositions for viral-associated tumors
FIVE3 GENOMICS LLC4 citations71
US12354709B2Jul 8, 2025
Systems, methods, and compositions for viral-associated tumors
FIVE3 GENOMICS LLC0 citations61
EASEL BIOTECHNOLOGIES LLC
2 patentsNantCell
2 patentsCHAN SOON SHIONG NANTHEALTH FOUND
1 patentNIAZI KAYVAN
1 patentRABIZADEH SHAHROOZ
1 patentBURNHAM INST
1 patentCHAN SOON SHIONG INST OF ADVANCED HEALTH
1 patentHIGASHIDE WENDY M
1 patentNANTBIO INC
1 patentShowing the top 50 of 85 patents by PatentIndex Score.